{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:39:51Z","timestamp":1780393191203,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Research Projects of Shanxi Province China","award":["202203021222341"],"award-info":[{"award-number":["202203021222341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrent observations have indicated the presence of deficits in mismatch negativity (MMN) among schizophrenia. There is evidence suggesting a correlation between increased dopaminergic activity and reduced MMN amplitude, but there is no consensus on whether antipsychotic medications can improve MMN deficit in schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted clinical assessments, cognitive function tests, and EEG data collection and analysis on 31 drug-na\u00efve patients with schizophrenia. Comprehensive evaluation tools such as PANSS and MCCB. MMN amplitude was analyzed by event-related potential (ERP) approaches, evoked theta power was analyzed by event-related spectral perturbation (ERSP) approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings indicate that antipsychotic treatment significantly improved clinical symptoms, as evidenced by reductions in PANSS positive, negative, general symptoms, and total scores (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Cognitive function improvements were observed in language learning, working memory, and overall MCCB scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), although other cognitive domains showed no significant changes. However, no significant improvements were noted in MMN amplitude and evoke theta power after four weeks of antipsychotic treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest that while antipsychotic medications effectively alleviate clinical symptoms, their impact on MMN amplitude and evoke theta power deficit is limited in the short term. Moreover, the amelioration of cognitive impairment in individuals with schizophrenia is not readily discernible, and it cannot be discounted that the enhancement observed in language acquisition and working memory may be attributed to a learning effect. These findings underscore the complexity of the neurobiological mechanisms involved and highlight the need for further research to optimize individualized treatment strategies for schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>ChiCTR2000038961, October 10, 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-024-06314-w","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:54:05Z","timestamp":1734501245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of antipsychotic on mismatch negativity amplitude and evoked theta power in drug-na\u00efve patients with schizophrenia"],"prefix":"10.1186","volume":"24","author":[{"given":"Yan-Bing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Jing","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Bo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"2","key":"6314_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020;77(2):201\u201310.","journal-title":"JAMA Psychiatry"},{"key":"6314_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-981-15-1792-1_21","volume":"1228","author":"J Bueno-Antequera","year":"2020","unstructured":"Bueno-Antequera J, Mungu\u00eda-Izquierdo D. Exercise and Schizophrenia. Adv Exp Med Biol. 2020;1228:317\u201332.","journal-title":"Adv Exp Med Biol"},{"issue":"10323","key":"6314_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ, Schizophrenia. Lancet (London England). 2022;399(10323):473\u201386.","journal-title":"Lancet (London England)"},{"issue":"1","key":"6314_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00003446-199502000-00002","volume":"16","author":"R N\u00e4\u00e4t\u00e4nen","year":"1995","unstructured":"N\u00e4\u00e4t\u00e4nen R. The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear. 1995;16(1):6\u201318.","journal-title":"Ear Hear"},{"issue":"2","key":"6314_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0301-0511(79)90053-X","volume":"8","author":"R N\u00e4\u00e4t\u00e4nen","year":"1979","unstructured":"N\u00e4\u00e4t\u00e4nen R, Michie PT. Early selective-attention effects on the evoked potential: a critical review and reinterpretation. Biol Psychol. 1979;8(2):81\u2013136.","journal-title":"Biol Psychol"},{"key":"6314_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fpsyt.2020.00468","volume":"11","author":"K Fitzgerald","year":"2020","unstructured":"Fitzgerald K, Todd J. Making sense of Mismatch Negativity. Front Psychiatry. 2020;11:468.","journal-title":"Front Psychiatry"},{"issue":"3","key":"6314_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clinph.2011.09.020","volume":"123","author":"R N\u00e4\u00e4t\u00e4nen","year":"2012","unstructured":"N\u00e4\u00e4t\u00e4nen R, Kujala T, Escera C, Baldeweg T, Kreegipuu K, Carlson S, Ponton C. The mismatch negativity (MMN)--a unique window to disturbed central auditory processing in ageing and different clinical conditions. Clin Neurophysiology: Official J Int Federation Clin Neurophysiol. 2012;123(3):424\u201358.","journal-title":"Clin Neurophysiology: Official J Int Federation Clin Neurophysiol"},{"key":"6314_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijpsycho.2019.02.009","volume":"145","author":"M Tada","year":"2019","unstructured":"Tada M, Kirihara K, Mizutani S, Uka T, Kunii N, Koshiyama D, Fujioka M, Usui K, Nagai T, Araki T, et al. Mismatch negativity (MMN) as a tool for translational investigations into early psychosis: a review. Int J Psychophysiology: Official J Int Organ Psychophysiol. 2019;145:5\u201314.","journal-title":"Int J Psychophysiology: Official J Int Organ Psychophysiol"},{"issue":"7","key":"6314_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.pnpbp.2006.03.003","volume":"30","author":"Y Kawakubo","year":"2006","unstructured":"Kawakubo Y, Kasai K. Support for an association between mismatch negativity and social functioning in schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry. 2006;30(7):1367\u20138.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1","key":"6314_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/schbul\/sbp060","volume":"37","author":"PE Rasser","year":"2011","unstructured":"Rasser PE, Schall U, Todd J, Michie PT, Ward PB, Johnston P, Helmbold K, Case V, S\u00f8yland A, Tooney PA, et al. Gray Matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull. 2011;37(1):131\u201340.","journal-title":"Schizophr Bull"},{"issue":"5","key":"6314_CR11","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28(5):1902\u201318.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"6314_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.schres.2004.09.008","volume":"72","author":"JM Gold","year":"2004","unstructured":"Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004;72(1):21\u20138.","journal-title":"Schizophr Res"},{"key":"6314_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnbeh.2019.00037","volume":"13","author":"YB Xiong","year":"2019","unstructured":"Xiong YB, Bo QJ, Wang CM, Tian Q, Liu Y, Wang CY. Differential of frequency and duration mismatch negativity and Theta Power deficits in First-Episode and Chronic Schizophrenia. Front Behav Neurosci. 2019;13:37.","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"6314_CR14","doi-asserted-by":"publisher","first-page":"pyv109","DOI":"10.1093\/ijnp\/pyv109","volume":"19","author":"S D\u00fcring","year":"2015","unstructured":"D\u00fcring S, Glenth\u00f8j BY, Oranje B. Effects of blocking D2\/D3 receptors on Mismatch Negativity and P3a Amplitude of initially antipsychotic Na\u00efve, First Episode Schizophrenia patients. Int J Neuropsychopharmacol. 2015;19(3):pyv109.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"6314_CR15","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1017\/S0033291717000599","volume":"47","author":"B Oranje","year":"2017","unstructured":"Oranje B, Aggernaes B, Rasmussen H, Ebdrup BH, Glenth\u00f8j BY. Selective attention and mismatch negativity in antipsychotic-na\u00efve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy. Psychol Med. 2017;47(12):2155\u201365.","journal-title":"Psychol Med"},{"issue":"9","key":"6314_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrn4002","volume":"16","author":"DC Javitt","year":"2015","unstructured":"Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nat Rev Neurosci. 2015;16(9):535\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"6314_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.schres.2017.06.023","volume":"191","author":"DC Javitt","year":"2018","unstructured":"Javitt DC, Lee M, Kantrowitz JT, Martinez A. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia. Schizophr Res. 2018;191:51\u201360.","journal-title":"Schizophr Res"},{"key":"6314_CR18","unstructured":"He YL, Zhang MY. The Positive and Negative Syndrome Scale (PANSS) and its application (in Chinese), vol. 7; 1997."},{"issue":"3","key":"6314_CR19","first-page":"189","volume":"27","author":"YX Pang","year":"2011","unstructured":"Pang YX, Zhang J, Yang CL, Cang Y, Wang XL. [Application of WAIS-RC short forms and adult intelligence disability scale in mental impairment assessment]. Fa Yi Xue Za Zhi. 2011;27(3):189\u201392.","journal-title":"Fa Yi Xue Za Zhi"},{"issue":"1\u20133","key":"6314_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","volume":"169","author":"C Shi","year":"2015","unstructured":"Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, Cheng Z, Xu Y, Shi J, Xu X, et al. The MATRICS Consensus Cognitive Battery (MCCB): co-norming and standardization in China. Schizophr Res. 2015;169(1\u20133):109\u201315.","journal-title":"Schizophr Res"},{"issue":"4","key":"6314_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S0033291712001535","volume":"43","author":"I Bombin","year":"2013","unstructured":"Bombin I, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, de la Serna E, Rapado-Castro M, Barbeito S, Parellada M, Baeza I, Graell M, et al. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med. 2013;43(4):757\u201368.","journal-title":"Psychol Med"},{"issue":"3","key":"6314_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/schbul\/sbn127","volume":"36","author":"M \u00d8ie","year":"2010","unstructured":"\u00d8ie M, Sundet K, Rund BR. Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study. Schizophr Bull. 2010;36(3):557\u201365.","journal-title":"Schizophr Bull"},{"issue":"1","key":"6314_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/a0016791","volume":"24","author":"C Jahshan","year":"2010","unstructured":"Jahshan C, Heaton RK, Golshan S, Cadenhead KS. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology. 2010;24(1):109\u201320.","journal-title":"Neuropsychology"},{"key":"6314_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fnhum.2013.00643","volume":"7","author":"HE Barder","year":"2013","unstructured":"Barder HE, Sundet K, Rund BR, Evensen J, Haahr U, Ten Velden Hegelstad W, Joa I, Johannessen JO, Langeveld J, Larsen TK, et al. Ten year neurocognitive trajectories in first-episode psychosis. Front Hum Neurosci. 2013;7:643.","journal-title":"Front Hum Neurosci"},{"key":"6314_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.schres.2017.04.031","volume":"192","author":"N Ohmuro","year":"2018","unstructured":"Ohmuro N, Katsura M, Obara C, Kikuchi T, Hamaie Y, Sakuma A, Iizuka K, Ito F, Matsuoka H, Matsumoto K. The relationship between cognitive insight and cognitive performance among individuals with at-risk mental state for developing psychosis. Schizophr Res. 2018;192:281\u20136.","journal-title":"Schizophr Res"},{"key":"6314_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eurpsy.2017.09.003","volume":"47","author":"\u0141 Gaw\u0119da","year":"2018","unstructured":"Gaw\u0119da \u0141, Li E, Lavoie S, Whitford TJ, Moritz S, Nelson B. Impaired action self-monitoring and cognitive confidence among ultra-high risk for psychosis and first-episode psychosis patients. Eur Psychiatry: J Association Eur Psychiatrists. 2018;47:67\u201375.","journal-title":"Eur Psychiatry: J Association Eur Psychiatrists"},{"issue":"8","key":"6314_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/arclin\/acx029","volume":"32","author":"C Zouraraki","year":"2017","unstructured":"Zouraraki C, Karamaouna P, Karagiannopoulou L, Giakoumaki SG. Schizotypy-Independent and Schizotypy-modulated cognitive impairments in Unaffected First-Degree relatives of Schizophrenia-spectrum patients. Archives Clin Neuropsychology: Official J Natl Acad Neuropsychologists. 2017;32(8):1010\u201325.","journal-title":"Archives Clin Neuropsychology: Official J Natl Acad Neuropsychologists"},{"issue":"6","key":"6314_CR28","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/schbul\/sbw023","volume":"42","author":"JL Molina","year":"2016","unstructured":"Molina JL, Gonz\u00e1lez Alem\u00e1n G, Florenzano N, Padilla E, Calv\u00f3 M, Guerrero G, Kamis D, Stratton L, Toranzo J, Molina Rangeon B, et al. Prediction of neurocognitive deficits by Parkinsonian Motor Impairment in Schizophrenia: a study in Neuroleptic-Na\u00efve subjects, Unaffected First-Degree relatives and healthy controls from an Indigenous Population. Schizophr Bull. 2016;42(6):1486\u201395.","journal-title":"Schizophr Bull"},{"key":"6314_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biopsycho.2015.10.010","volume":"116","author":"R N\u00e4\u00e4t\u00e4nen","year":"2016","unstructured":"N\u00e4\u00e4t\u00e4nen R, Todd J, Schall U. Mismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals. Biol Psychol. 2016;116:36\u201340.","journal-title":"Biol Psychol"},{"issue":"12","key":"6314_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.biopsych.2015.08.025","volume":"79","author":"MA Erickson","year":"2016","unstructured":"Erickson MA, Ruffle A, Gold JM. A Meta-analysis of Mismatch Negativity in Schizophrenia: from clinical risk to Disease specificity and progression. Biol Psychiatry. 2016;79(12):980\u20137.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"6314_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archpsyc.64.5.521","volume":"64","author":"DF Salisbury","year":"2007","unstructured":"Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry. 2007;64(5):521\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"6314_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fpsyt.2013.00171","volume":"4","author":"J Todd","year":"2013","unstructured":"Todd J, Harms L, Schall U, Michie PT. Mismatch negativity: translating the potential. Front Psychiatry. 2013;4:171.","journal-title":"Front Psychiatry"},{"issue":"1","key":"6314_CR33","doi-asserted-by":"publisher","first-page":"e52186","DOI":"10.1371\/journal.pone.0052186","volume":"8","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Zhu H, Chen L. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia. PLoS ONE. 2013;8(1):e52186.","journal-title":"PLoS ONE"},{"issue":"8","key":"6314_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1177\/0269881109102606","volume":"24","author":"M Wienberg","year":"2010","unstructured":"Wienberg M, Glenthoj BY, Jensen KS, Oranje B. A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. J Psychopharmacol (Oxford England). 2010;24(8):1183\u201392.","journal-title":"J Psychopharmacol (Oxford England)"},{"issue":"4","key":"6314_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.pnpbp.2005.01.019","volume":"29","author":"M Korostenskaja","year":"2005","unstructured":"Korostenskaja M, Dapsys K, Siurkute A, Maciulis V, Ruksenas O, K\u00e4hk\u00f6nen S. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuro-psychopharmacol Biol Psychiatry. 2005;29(4):543\u20138.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"6314_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsycho.2015.10.013","volume":"116","author":"VS Catts","year":"2016","unstructured":"Catts VS, Lai YL, Weickert CS, Weickert TW, Catts SV. A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: how can we link molecular abnormalities to mismatch negativity deficits? Biol Psychol. 2016;116:57\u201367.","journal-title":"Biol Psychol"},{"issue":"21","key":"6314_CR37","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1073\/pnas.93.21.11962","volume":"93","author":"DC Javitt","year":"1996","unstructured":"Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA. 1996;93(21):11962\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"38","key":"6314_CR38","doi-asserted-by":"publisher","first-page":"15425","DOI":"10.1073\/pnas.1312264110","volume":"110","author":"R Gil-da-Costa","year":"2013","unstructured":"Gil-da-Costa R, Stoner GR, Fung R, Albright TD. Nonhuman primate model of schizophrenia using a noninvasive EEG method. Proc Natl Acad Sci USA. 2013;110(38):15425\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"6314_CR39","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.clinph.2015.10.062","volume":"127","author":"T Rosburg","year":"2016","unstructured":"Rosburg T, Kreitschmann-Andermahr I. The effects of ketamine on the mismatch negativity (MMN) in humans - a meta-analysis. Clin Neurophysiology: Official J Int Federation Clin Neurophysiol. 2016;127(2):1387\u201394.","journal-title":"Clin Neurophysiology: Official J Int Federation Clin Neurophysiol"},{"issue":"2","key":"6314_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-009-1723-0","volume":"208","author":"S Leung","year":"2010","unstructured":"Leung S, Croft RJ, Guille V, Scholes K, O\u2019Neill BV, Phan KL, Nathan PJ. Acute dopamine and\/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology. 2010;208(2):233\u201344.","journal-title":"Psychopharmacology"},{"key":"6314_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.schres.2017.02.027","volume":"191","author":"JT Kantrowitz","year":"2018","unstructured":"Kantrowitz JT, Epstein ML, Lee M, Lehrfeld N, Nolan KA, Shope C, Petkova E, Silipo G, Javitt DC. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: correlation with symptoms. Schizophr Res. 2018;191:70\u20139.","journal-title":"Schizophr Res"},{"key":"6314_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2017.05.031","volume":"191","author":"LM Greenwood","year":"2018","unstructured":"Greenwood LM, Leung S, Michie PT, Green A, Nathan PJ, Fitzgerald P, Johnston P, Solowij N, Kulkarni J, Croft RJ. The effects of glycine on auditory mismatch negativity in schizophrenia. Schizophr Res. 2018;191:61\u20139.","journal-title":"Schizophr Res"},{"issue":"3","key":"6314_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/npp.2017.176","volume":"43","author":"M Lee","year":"2018","unstructured":"Lee M, Balla A, Sershen H, Sehatpour P, Lakatos P, Javitt DC. Rodent mismatch Negativity\/theta Neuro-Oscillatory response as a translational neurophysiological biomarker for N-Methyl-D-Aspartate receptor-based New Treatment Development in Schizophrenia. Neuropsychopharmacology: Official Publication Am Coll Neuropsychopharmacol. 2018;43(3):571\u201382.","journal-title":"Neuropsychopharmacology: Official Publication Am Coll Neuropsychopharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06314-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:07:37Z","timestamp":1734505657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06314-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6314"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06314-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5049624\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study obtained approval from the Ethics Committee of Beijing Anding Hospital (LL-SQ-fj-3.8.1\u20131.3) and all subjects provided informed consent before participating (1.2\/ 2017.07.07).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as we do not provide personal information for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}